Article info
Original article
Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen
- Correspondence to Dr Cameron E Snell, The Department of Anatomical Pathology, Mater Pathology, Mater Hospital Brisbane, Level 3 Duncombe Building, Raymond Terrace, South Brisbane, QLD 4101, Australia; cameron.snell{at}gmail.com
Citation
Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen
Publication history
- Received December 22, 2016
- Revised March 14, 2017
- Accepted March 29, 2017
- First published April 17, 2017.
Online issue publication
October 25, 2017
Article Versions
- Previous version (17 April 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/